Law360, New York (July 12, 2012, 1:18 PM EDT) -- Chad Landmon is a partner with Axinn Veltrop & Harkrider LLP in the firm's Hartford, Conn., and Washington, D.C., offices. He co-chairs the firm's intellectual property practice and chairs the U.S. Food and Drug Administration practice. Landmon focuses on litigating and counseling issues surrounding the development and marketing of drug products and human tissue products. His litigation practice is national in scope and focuses on life sciences and Paragraph IV pharmaceutical patent litigation. He serves on the Drugs and Biologics Committee of the Food and Drug Law Institute, and he is co-chairman of the Biologics Subcommittee of the FDA Special Committee for the American Intellectual Property Law Association....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
